Compile Data Set for Download or QSAR
maximum 50k data
Found 141 Enz. Inhib. hit(s) with Target = 'Sepiapterin reductase'
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187257(US9169234, 22)
Affinity DataIC50:  11nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the produc...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187256(US9169234, 21)
Affinity DataIC50:  84nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the produc...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187259(US9169234, 24)
Affinity DataIC50:  310nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the produc...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187260(US9169234, 32)
Affinity DataIC50:  64nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the produc...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187261(US9169234, 12)
Affinity DataIC50:  2.10E+3nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the produc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187250(US9169234, 1)
Affinity DataIC50:  330nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the product ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187251(US9169234, 2)
Affinity DataIC50:  340nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the product ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187252(US9169234, 3)
Affinity DataIC50:  2.20E+3nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the product ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187253(US9169234, 16)
Affinity DataIC50:  2.80E+3nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the product ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187254(US9169234, 17)
Affinity DataIC50:  3.20E+3nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the product ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187255(US9169234, 18)
Affinity DataIC50:  1.00E+3nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the product ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187256(US9169234, 21)
Affinity DataIC50:  86nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the product ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187257(US9169234, 22)
Affinity DataIC50:  19nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the product ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187258(US9169234, 23)
Affinity DataIC50:  12nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the product ...More data for this Ligand-Target Pair
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187259(US9169234, 24)
Affinity DataIC50:  310nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the product ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187260(US9169234, 32)
Affinity DataIC50:  69nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the product ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187261(US9169234, 12)
Affinity DataIC50:  1.60E+3nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the product ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187250(US9169234, 1)
Affinity DataIC50:  400nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the produc...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187251(US9169234, 2)
Affinity DataIC50:  360nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the produc...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187252(US9169234, 3)
Affinity DataIC50:  2.80E+3nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the produc...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187253(US9169234, 16)
Affinity DataIC50:  3.40E+3nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the produc...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187254(US9169234, 17)
Affinity DataIC50:  4.50E+3nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the produc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187255(US9169234, 18)
Affinity DataIC50:  1.10E+3nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the produc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187258(US9169234, 23)
Affinity DataIC50:  11nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the produc...More data for this Ligand-Target Pair
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM50515121(CHEMBL4580809)
Affinity DataIC50:  5.10E+3nMAssay Description:Inhibition of TNAS binding to human sepiapterin reductase by 19F-NMR spectra analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM50515122(CHEMBL4586653)
Affinity DataIC50:  550nMAssay Description:Inhibition of TNAS binding to human sepiapterin reductase by 19F-NMR spectra analysisMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM50515123(CHEMBL4448911)
Affinity DataIC50:  310nMAssay Description:Inhibition of TNAS binding to human sepiapterin reductase by 19F-NMR spectra analysisMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM50515124(CHEMBL4450659)
Affinity DataIC50:  7.72E+3nMAssay Description:Inhibition of TNAS binding to human sepiapterin reductase by 19F-NMR spectra analysisMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM50515125(CHEMBL4562659)
Affinity DataIC50:  290nMAssay Description:Inhibition of TNAS binding to human sepiapterin reductase by 19F-NMR spectra analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM50515126(CHEMBL4451547)
Affinity DataIC50:  40nMAssay Description:Inhibition of TNAS binding to human sepiapterin reductase by 19F-NMR spectra analysisMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM50515127(CHEMBL4458013)
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of TNAS binding to human sepiapterin reductase by 19F-NMR spectra analysisMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM50515128(CHEMBL4519901)
Affinity DataIC50:  670nMAssay Description:Inhibition of TNAS binding to human sepiapterin reductase by 19F-NMR spectra analysisMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM50515129(CHEMBL4583967)
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of TNAS binding to human sepiapterin reductase by 19F-NMR spectra analysisMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM50515130(CHEMBL4581601)
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of TNAS binding to human sepiapterin reductase by 19F-NMR spectra analysisMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM50515131(CHEMBL4460615)
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of TNAS binding to human sepiapterin reductase by 19F-NMR spectra analysisMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM50515132(CHEMBL4570977)
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of TNAS binding to human sepiapterin reductase by 19F-NMR spectra analysisMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM50515133(CHEMBL4438507)
Affinity DataIC50:  4.04E+3nMAssay Description:Inhibition of TNAS binding to human sepiapterin reductase by 19F-NMR spectra analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM50515134(CHEMBL4457055)
Affinity DataIC50:  7.48E+3nMAssay Description:Inhibition of TNAS binding to human sepiapterin reductase by 19F-NMR spectra analysisMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM50515135(CHEMBL4459770)
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of TNAS binding to human sepiapterin reductase by 19F-NMR spectra analysisMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM50515136(CHEMBL4441521)
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of TNAS binding to human sepiapterin reductase by 19F-NMR spectra analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM50515137(CHEMBL4476837)
Affinity DataIC50:  57nMAssay Description:Inhibition of TNAS binding to human sepiapterin reductase by 19F-NMR spectra analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM50515138(CHEMBL4457905)
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of TNAS binding to human sepiapterin reductase by 19F-NMR spectra analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM50515139(CHEMBL4456955)
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of TNAS binding to human sepiapterin reductase by 19F-NMR spectra analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM50515140(CHEMBL4451733)
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of TNAS binding to human sepiapterin reductase by 19F-NMR spectra analysisMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM50515141(CHEMBL4518154)
Affinity DataIC50:  1.55E+3nMAssay Description:Inhibition of TNAS binding to human sepiapterin reductase by 19F-NMR spectra analysisMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM50515142(CHEMBL4460134)
Affinity DataIC50:  83nMAssay Description:Inhibition of TNAS binding to human sepiapterin reductase by 19F-NMR spectra analysisMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM50515143(CHEMBL4566881)
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of TNAS binding to human sepiapterin reductase by 19F-NMR spectra analysisMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM50515144(CHEMBL4445774)
Affinity DataIC50:  4.78E+3nMAssay Description:Inhibition of TNAS binding to human sepiapterin reductase by 19F-NMR spectra analysisMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM50515145(CHEMBL4556522)
Affinity DataIC50:  980nMAssay Description:Inhibition of TNAS binding to human sepiapterin reductase by 19F-NMR spectra analysisMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM50515146(CHEMBL4582418)
Affinity DataIC50:  5.85E+3nMAssay Description:Inhibition of TNAS binding to human sepiapterin reductase by 19F-NMR spectra analysisMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 141 total ) | Next | Last >>
Jump to: